Regulation/NN
and/CC
specificity/NN
of/IN
MNDA/NN
expression/NN
in/IN
monocytes/NNS
,/,
macrophages/NNS
,/,
and/CC
leukemia/B/NN
lymphoma/NN
cell/NN
lines/NNS
./.

The/DT
expression/NN
of/IN
the/DT
human/JJ
myeloid/JJ
cell/NN
nuclear/JJ
differentiation/NN
antigen/NN
(/(
MNDA/NN
)/)
was/VBD
observed/VBN
specifically/RB
in/IN
cells/NNS
of/IN
the/DT
granulocyte-macrophage/JJ
lineage/NN
in/IN
our/PRP$
earlier/JJR
reports/NNS
./.
=====
The/DT
specificity/NN
of/IN
MNDA/NN
expression/NN
for/IN
cells/NNS
in/IN
the/DT
granulocyte-macrophage/NN
lineage/NN
was/VBD
reexamined/VBN
in/IN
cell/NN
lines/NNS
established/VBN
from/IN
patients/NNS
with/IN
Philadelphia/NN
chromosome-positive/JJ
chronic/JJ
myeloid/JJ
leukemia/NN
./.
=====
Cell/NN
lines/NNS
that/WDT
expressed/VBD
MNDA/NN
exhibited/VBD
myeloid/JJ
cell/NN
features/NNS
and/CC
granulocyte/NN
or/CC
monocyte/NN
differentiation/NN
could/MD
be/VB
induced/VBN
in/FW
vitro/FW
,/,
while/IN
cell/NN
lines/NNS
exhibiting/VBG
properties/NNS
of/IN
very/RB
early/JJ
stage/NN
cells/NNS
or/CC
multipotential/JJ
cells/NNS
did/VBD
not/RB
express/VB
MNDA/NN
./.
=====
Cells/NNS
originating/VBG
from/IN
cases/NNS
of/IN
Burkitt/NN
's/POS
lymphoma/NN
were/VBD
negative/JJ
./.
=====
By/IN
contrast/NN
,/,
three/CD
lymphoblastoid/JJ
cell/NN
lines/NNS
(/(
immortalized/VBN
in/FW
vitro/FW
with/IN
Epstein-Barr/JJ
virus/NN
)/)
were/VBD
weakly/RB
positive/JJ
and/CC
MNDA/NN
was/VBD
up-regulated/VBN
by/IN
interferon-alpha/NN
(/(
IFN-alpha/NN
)/)
treatment/NN
./.
=====
As/IN
we/PRP
reported/VBD
previously/RB
,/,
MNDA/NN
mRNA/NN
level/NN
in/IN
adherent/JJ
monocytes/NNS
is/VBZ
elevated/VBN
by/IN
IFN-alpha/NN
;/:
in/IN
this/DT
study/NN
,/,
we/PRP
further/RB
assessed/VBD
MNDA/NN
expression/NN
in/IN
in/FW
vitro/FW
monocyte-derived/JJ
macrophages/NNS
./.
=====
Three/CD
additional/JJ
agents/NNS
(/(
endotoxin/NN
,/,
phytohemagglutinin/NN
,/,
and/CC
phorbol/NN
ester/NN
)/)
and/CC
other/JJ
conditions/NNS
that/WDT
affect/VBP
function/NN
,/,
cytokine/NN
production/NN
,/,
differentiation/NN
,/,
and/or/CC
growth/NN
of/IN
monocytes/NNS
were/VBD
examined/VBN
for/IN
their/PRP$
ability/NN
to/TO
alter/VB
MNDA/NN
expression/NN
./.
=====
The/DT
results/NNS
varied/VBD
with/IN
the/DT
agent/NN
,/,
cell/NN
type/NN
,/,
and/CC
stage/NN
of/IN
differentiation/NN
./.
=====
Changes/NNS
in/IN
MNDA/NN
expression/NN
occurred/VBD
slowly/RB
(/(
hours/NNS
to/TO
days/NNS
)/)
,/,
suggesting/VBG
that/IN
MNDA/NN
could/MD
mediate/VB
changes/NNS
realized/VBN
over/IN
a/DT
long/JJ
period/NN
./.
=====
The/DT
results/NNS
also/RB
reveal/VBP
a/DT
discordance/NN
in/IN
certain/JJ
MNDA/NN
positive/JJ
cells/NNS
between/IN
steady-state/JJ
levels/NNS
or/CC
changes/NNS
in/IN
levels/NNS
of/IN
protein/NN
and/CC
mRNA/NN
indicating/VBG
that/IN
the/DT
regulation/NN
of/IN
MNDA/NN
expression/NN
occurs/VBZ
at/IN
more/JJR
than/IN
one/CD
point/NN
./.
=====
Changes/NNS
in/IN
MNDA/NN
expression/NN
are/VBP
consistent/JJ
with/IN
a/DT
role/NN
in/IN
opposing/VBG
macrophage/NN
differentiation/NN
and/CC
activation/NN
of/IN
monocytes/macrophages/NNS
./.